HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma

被引:471
作者
Dupin, N
Diss, TL
Kellam, P
Tulliez, M
Du, MQ
Sicard, D
Weiss, RA
Isaacson, PG
Boshoff, C
机构
[1] UCL, Dept Histopathol, London WC1E 6JJ, England
[2] UCL, Dept Oncol, London WC1E 6JJ, England
[3] UCL, Dept Mol Pathol, London WC1E 6JJ, England
[4] Hop Tarnier Cochin, NADER, Dept Dermatol, Paris, France
[5] Hop Cochin, Dept Histopathol & Internal Med, F-75674 Paris, France
关键词
D O I
10.1182/blood.V95.4.1406.004k26_1406_1412
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Castleman disease (CD) is a lymphoproliferative disorder of unknown etiology that is associated with the development of secondary tumors, including B-cell lymphoma. Human herpesvirus 8 (HHV-8) (Kaposi's sarcoma-associated herpesvirus) sequences have been described in some cases of multicentric Castleman disease (MCD). Using a monoclonal anti-body against an HHV-8-latent nuclear antigen, we show that HHV-8 is specifically associated with a variant of MCD in which HHV-8-positive plasmablasts that show lambda light-chain restriction localize in the mantle zone of B-cell follicles and coalesce to form microscopic lymphomas in some cases. Furthermore, we show that the frank plasmablastic lymphoma that develops in patients with this plasmablastic Variant of MCD is also positive for HHV-8 and lambda light chain. Plasmablastic lymphoma associated with MCD is a new disease entity associated with HHV-8 infection, (C) 2000 by The American Society of Hematology.
引用
收藏
页码:1406 / 1412
页数:7
相关论文
共 53 条
  • [1] AbdelReheim FA, 1996, ARCH PATHOL LAB MED, V120, P91
  • [2] Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen
    Ballestas, ME
    Chatis, PA
    Kaye, KM
    [J]. SCIENCE, 1999, 284 (5414) : 641 - 644
  • [3] Barozzi P, 1996, J CLIN PATHOL-CL MOL, V49, pM232
  • [4] Boshoff, 1996, LANCET, V348, P138
  • [5] Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice
    Boshoff, C
    Gao, SJ
    Healy, LE
    Matthews, S
    Thomas, AJ
    Coignet, L
    Warnke, RA
    Strauchen, JA
    Matutes, E
    Kamel, OW
    Moore, PS
    Weiss, RA
    Chang, Y
    [J]. BLOOD, 1998, 91 (05) : 1671 - 1679
  • [6] HHV8 and skin cancers in immunosuppressed patients
    Boshoff, C
    Talbot, S
    Kennedy, M
    OLeary, J
    Schulz, T
    Chang, Y
    [J]. LANCET, 1996, 347 (8997) : 338 - 339
  • [7] Boshoff Chris, 1999, V33, P157
  • [8] BROUSSET P, 1993, LAB INVEST, V69, P483
  • [9] Brown WB, 1999, CANCER, V85, P706
  • [10] CASTLEMAN B, 1956, CANCER, V9, P822, DOI 10.1002/1097-0142(195607/08)9:4<822::AID-CNCR2820090430>3.0.CO